Vol. 1 No. 2 (2026): European Journal of Molecular Pharmacy

Published: 2026-06-04

Articles

AI-Integrated Drug–Target Interaction Prediction for High-Affinity Kinase Inhibitors Using Molecular Modeling and Virtual Screening

Yaping Sun (Author)

97-105
- PDF
Rarity Redefined: Anti-Ku Antibody–Associated Myopathy In a Child

Sabavath Arun, Shivangi Sinha, Shivani Khandelwal (Author)

27-31
- PDF
Machine Learning-Based Prediction of Drug–Target Binding Affinity Using Molecular Structures and Protein Sequences: A Comparative Analysis of Davis and KIBA Datasets

Sheo Kumar (Author)

106-115
- PDF
Therapeutic Enzymes in Modern Medicine: Biocatalytic Mechanisms, Clinical Applications, Engineering and Challenges

Akash Sarkar, Tamanna Khatun, Akhmetgaleeva Aliya Fanilievna (Author)

32-48
- PDF
Computational Identification of High-Affinity Kinase Inhibitors through Molecular Representation Learning and Drug–Target Interaction Modeling

Shahid Ali, Abdelbaset Mohamed Elasbali (Author)

116-129
- PDF
ALDH1A1 Expression in Colorectal Carcinoma: Immunohistochemical Evaluation and Correlation with Pathological Prognostic Factors

Dr Somansh Goyal, Dr Clement Wilfred D. (Author)

49-59
- PDF
Polycystic Ovary Syndrome and the Imperative for Personalized Dosing: Bridging the Gap Between Phenotypic Heterogeneity and Individualized Pharmacotherapy

Alekhya Ayitha, Merugu Samyuktha, Saka Sai Shree (Author)

01-14
- PDF
Nanotechnology-Enabled Drug Delivery Systems: Molecular Design, Therapeutic Applications, and Future Perspectives

Miss. Bindu Gajanan (Author)

60-74
- PDF
Urinary Free Cortisol Assessment for the Detection of Occult Hypercortisolism in Type 2 Diabetes Mellitus with Difficult-to-Control Hypertension: Clinical Insights from a Prospective Case Series

Soumik Chatterjee, Soumya Patra (Author)

15-20
- PDF
Artificial Intelligence in Molecular Drug Discovery: Advances in Computational Pharmacology, Rational Drug Design, and Translational Therapeutics

E. Sila Ozdemir (Author)

75-96
- PDF
Semaglutide as a Renoprotective Metabolic Modulator in Diabetic Nephropathy: An Expanded Case Series from West Bengal, India

Dr Soumik Chatterjee (Author)

21-26
- PDF